Last chance to save on Digiday Publishing Summit passes is February 9
Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
‘Our marketing is not a bullshit machine’: Why Perplexity is investing in targeted, organic growth
Perplexity is banking on its name carrying weight to keep current users engaged and attract new ones
As AI catches on across luxury, brands play up their emotional value
At Shoptalk Luxe, vendors and brands alike described deeper AI integration than ever before.
Future of Marketing Briefing: Advertising’s tracking system meets a new political reality
The privacy debate in advertising is entering a phase when decisions will stick.